BioCentury | May 12, 2017
Financial News

Drug delivery play Lamellar raises L5.8M series C

...On May 5, drug delivery company Lamellar Biomedical Ltd. (Bellshill, U.K.) raised £5.8 million ($7.5 million) in a...
...round led by Invesco Asset Management. Scottish Investment Bank also participated. Lamellar Biomedical Ltd. , Bellshill, U.K. Julian Zhu Lamellar Biomedical Ltd....
BioCentury | Mar 14, 2016
Company News

Lamellar Biomedical, University of Edinburgh deal

...mucosal surfaces and topical infection.” The partners declined to provide further details or financial terms. Lamellar Biomedical Ltd....
BioCentury | Aug 3, 2015
Financial News

Lamellar Biomedical completes venture financing

Lamellar Biomedical Ltd. , Bellshil, U.K. Business: Pulmonary, Drug delivery Date completed: 2015-07-24 Type: Venture financing Raised: L2.3 million ($3.6 million) Investors: Invesco; Scottish Investment Bank; Barwell plc; Tri Capital Ltd.; private investors WIR Staff...
BioCentury | Jun 27, 2011
Clinical News

LMS-611 regulatory update

...to start Phase I testing of the surface active phospholipid for the indication in 1Q12. Lamellar Biomedical Ltd....
Items per page:
1 - 4 of 4
BioCentury | May 12, 2017
Financial News

Drug delivery play Lamellar raises L5.8M series C

...On May 5, drug delivery company Lamellar Biomedical Ltd. (Bellshill, U.K.) raised £5.8 million ($7.5 million) in a...
...round led by Invesco Asset Management. Scottish Investment Bank also participated. Lamellar Biomedical Ltd. , Bellshill, U.K. Julian Zhu Lamellar Biomedical Ltd....
BioCentury | Mar 14, 2016
Company News

Lamellar Biomedical, University of Edinburgh deal

...mucosal surfaces and topical infection.” The partners declined to provide further details or financial terms. Lamellar Biomedical Ltd....
BioCentury | Aug 3, 2015
Financial News

Lamellar Biomedical completes venture financing

Lamellar Biomedical Ltd. , Bellshil, U.K. Business: Pulmonary, Drug delivery Date completed: 2015-07-24 Type: Venture financing Raised: L2.3 million ($3.6 million) Investors: Invesco; Scottish Investment Bank; Barwell plc; Tri Capital Ltd.; private investors WIR Staff...
BioCentury | Jun 27, 2011
Clinical News

LMS-611 regulatory update

...to start Phase I testing of the surface active phospholipid for the indication in 1Q12. Lamellar Biomedical Ltd....
Items per page:
1 - 4 of 4